Risk of cataract surgery in HIV-infected individuals: A danish nationwide population-based cohort study

Clinical Infectious Diseases

Volumn 53, Issue 11, 2011, Pages 1156-1163

  Rasmussen, Line D ^a   Kessel, Line ^b   Molander, Laleh D ^c   Pedersen, Court ^a   Gerstoft, Jan ^d   Kronborg, Gitte ^b   Obel, Niels ^d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Copenhagen University Hospital ^*  (Denmark)

^c LILLEBAELT HOSPITAL   (Denmark)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; TENOFOVIR;

ADULT; AGE; ARTICLE; CATARACT EXTRACTION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DENMARK; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGING; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CATARACT; CATARACT EXTRACTION; COHORT STUDIES; DENMARK; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; RISK ASSESSMENT;

EID: 80755172441     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir675     Document Type: Article

References (40)

1. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008;372:293-9.
2. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark 1995-2005. Ann Intern Med 2007;146:87-95. (Pubitemid 351640011)
3. Deeks SG. HIV Infection, inflammation, immunosenscence and aging. Annu Rev Med 2011;62:141-55.
4. The antiretroviral therapy cohort collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010;50:1387-96.
5. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment. Bull World Health Organ 2004;82:844-51.
6. Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Agerelated cataract. Lancet 2005;365:599-609.
7. Hodge WG, Whitcher JP, Satariano W. Risk factors for age-related cataracts. Epidemiol Rev 1995;17:336-46. (Pubitemid 26096878)
8. Shinohara T, White H, Mulhern ML, Maisel H. Cataract: window for systemic disorders. Med Hypotheses 2007;69:669-77. (Pubitemid 47049774)
9. Robman L, Taylor H. External factors in the development of cataract. Eye (Lond) 2005;19:1074-82. (Pubitemid 41823766)
10. Nemet AY, Vinker S, Levartovsky S, Kaiserman I. Is cataract associated with cardiovascular morbidity. Eye (Lond) 2010;24:1352-8.
11. Pollreeisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol 2010: 608751 Epub. 2010 Jun 17.
12. Carnahan MC, Goldstein DA. Ocular complications of topical, periocular, and systemic corticosteroids. Curr Opin Ophthalmol 2000;11:478-83.
13. Jancevski M, Foster CS. Cataracts and uveitis. Curr Opin Ophthalmol 2010;21:10-4.
14. Goldberg DE, Smithen LM, Angelilli A, Freeman WR. HIV-associated retinopathy in the HAART era. Retina 2005;140:633-49.
15. Robinson MR, Reed G, Csaky KG, Polis MA, Whitcup SM. Immunerecovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol 2000;130:49-56.
16. Karavellas MP, Plummer DJ, Macdonald JC, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis 1999;179:697-700. (Pubitemid 30016157)
17. Holand GN. AIDS and ophthalmolology: the first quarter century. Am J Ophthalol 2008;145:397-408.
18. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL;Studies of Ocular Complications of AIDS Research Group. Courses of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 2006;113:1441-5. (Pubitemid 44108167)
19. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Studies of the Ocular Complications of AIDS Research Group. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology 2007;114:787-93. (Pubitemid 46483694)
20. Statistics Denmark. Population and elections. Available at: http://www.dst.dk/HomeUK/Statistics/Key-indicators/Population/pop.aspx. Accessed 5 April 2011.
21. Lohse N, Hansen AB, Jensen-Fangel S, et al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005;37:338-43. (Pubitemid 40691514)
22. Obel N, Engsig FN, Rasmussen LD, Larsen MV, OmLand LH, Sørensen HT. Cohort profile: the Danish HIV Cohort Study. Int J Epidemiol 2009;38:1202-6.
23. Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-9. (Pubitemid 30185417)
24. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8.
25. The National Board of Health. Available at: http://www.sst.dk/ Indberetning%20og%20statistik/Landspatientregisteret/TEST-FaellesIndhold/10-2. aspx and http://www.medinfo.dk/sks/brows.php. Accessed Feb 2011.
26. Schnaudigel OE, Gümbel H, Richter R, Subklew R, Garweg T. Ophthalmologic manifestations in early and late stages of AIDS [in German]. Ophthalmologe 1994;91:668-70. (Pubitemid 24350403)
27. Nwosu NN. HIV/AIDS in ophthalmic patients: the Guinness Eye Centre Ornitsha experience. Niger Postgrad Med J 2008;15:24-7.
28. Pathanapitoon K, Riemens A, Kongyai N, et al. Intraocular and plasma HIV-1 RNA loads an HIV uveitis. AIDS 2011;25:81-6.
29. Rothova A, Schneider M, de Groot-Mijnes JD. Human immunodeficiency virus-induced uveitis: intraocular and plasma human immunodeficiency virus-1 RNA loads. Ophthalmology 2008;115:2062-4.
30. Rosberger DF, Heinemaann MH, Friedberg DN, Holland GN. Uveitis associated with human immunodeficiency virus infection. Am J Ophthalmol 1998;125:301-5. (Pubitemid 28124357)
31. Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 2000;129: 634-9. (Pubitemid 30323730)
32. Gharai S, Venkatesh P, Garg S, Sharma SK, Vohra R. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care centre in India. Ophthalmic Epidemiol 2008;15:264-71.
33. Goldberg DE, Wang H, Azen SP, Freeman WR. Long-term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy. Br J Ophthalmol 2003;87:853-5. (Pubitemid 36765248)
34. Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology 2007;114:591-8.
35. Accorinti M, Pirraglia MP, Corradi R, Corsi C, Fabiani C, Pivetti-Pezzi P. Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART. Eur J Ophthalmol 2006;16: 728-32. (Pubitemid 44870756)
36. Delcourt C, Cristol JP, Tessier F, Léger CL, Michel F, Papoz F. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liées àl'Age. Am J Epidemiol 2000;151:497-504. (Pubitemid 30471024)
37. D: A:D study group, Friis-Moller N, Reiss P, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356:1723-35. (Pubitemid 46658704)
38. Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 2007;44:1625-31. (Pubitemid 46871511)
39. Currier JS, Lundgren JD, Carr A, et al. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 2008;118:e29-35.
40. Kaplan RC, Kingsley LA, Sharrett AR, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis 2007;45:1074-81. (Pubitemid 47580361)